0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Medical AI-assisted Diagnosis Software Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-16V17103
Home | Market Reports | Health
Global Medical AI assisted Diagnosis Software Market Research Report 2024
BUY CHAPTERS

Global Medical AI-assisted Diagnosis Software Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-16V17103
Report
November 2025
Pages:153
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Medical AI-assisted Diagnosis Software Market

The global Medical AI-assisted Diagnosis Software market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Medical AI-assisted Diagnosis Software leading manufacturers including Sense Time, United Imaging, Huiying Medical, Yizhun, BioMind, Shukun, Lepu Medical, Infervision, NeuMiva, Baidu Lingyi, etc., dominate supply; the top five capture approximately % of global revenue, with Sense Time leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Medical AI-assisted Diagnosis Software market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Medical AI-assisted Diagnosis Software Market Report

Report Metric Details
Report Name Medical AI-assisted Diagnosis Software Market
Segment by Type
  • Lung AI-assisted Diagnosis Software
  • Bone AI-assisted Diagnosis Software
  • Cardiovascular and Cerebrovascular AI-assisted Diagnosis Software
  • Breast AI-assisted Diagnosis Software
  • Ophthalmic AI-assisted Diagnosis Software
  • Other AI-assisted Diagnosis Software
Segment by Application
  • Hospital
  • Clinic
  • Imaging Center
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sense Time, United Imaging, Huiying Medical, Yizhun, BioMind, Shukun, Lepu Medical, Infervision, NeuMiva, Baidu Lingyi, Tencent Health, Deepwise, VoxelCloud, Wision, ZHENHEALTH, G K Healthcare
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Medical AI-assisted Diagnosis Software study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Medical AI-assisted Diagnosis Software Market report?

Ans: The main players in the Medical AI-assisted Diagnosis Software Market are Sense Time, United Imaging, Huiying Medical, Yizhun, BioMind, Shukun, Lepu Medical, Infervision, NeuMiva, Baidu Lingyi, Tencent Health, Deepwise, VoxelCloud, Wision, ZHENHEALTH, G K Healthcare

What are the Application segmentation covered in the Medical AI-assisted Diagnosis Software Market report?

Ans: The Applications covered in the Medical AI-assisted Diagnosis Software Market report are Hospital, Clinic, Imaging Center

What are the Type segmentation covered in the Medical AI-assisted Diagnosis Software Market report?

Ans: The Types covered in the Medical AI-assisted Diagnosis Software Market report are Lung AI-assisted Diagnosis Software, Bone AI-assisted Diagnosis Software, Cardiovascular and Cerebrovascular AI-assisted Diagnosis Software, Breast AI-assisted Diagnosis Software, Ophthalmic AI-assisted Diagnosis Software, Other AI-assisted Diagnosis Software

1 Study Coverage
1.1 Introduction to Medical AI-assisted Diagnosis Software: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Medical AI-assisted Diagnosis Software Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Lung AI-assisted Diagnosis Software
1.2.3 Bone AI-assisted Diagnosis Software
1.2.4 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Software
1.2.5 Breast AI-assisted Diagnosis Software
1.2.6 Ophthalmic AI-assisted Diagnosis Software
1.2.7 Other AI-assisted Diagnosis Software
1.3 Market Segmentation by Application
1.3.1 Global Medical AI-assisted Diagnosis Software Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Imaging Center
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Medical AI-assisted Diagnosis Software Revenue Estimates and Forecasts 2020-2031
2.2 Global Medical AI-assisted Diagnosis Software Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Medical AI-assisted Diagnosis Software Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Medical AI-assisted Diagnosis Software Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Lung AI-assisted Diagnosis Software Market Size by Players
3.3.2 Bone AI-assisted Diagnosis Software Market Size by Players
3.3.3 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Software Market Size by Players
3.3.4 Breast AI-assisted Diagnosis Software Market Size by Players
3.3.5 Ophthalmic AI-assisted Diagnosis Software Market Size by Players
3.3.6 Other AI-assisted Diagnosis Software Market Size by Players
3.4 Global Medical AI-assisted Diagnosis Software Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Medical AI-assisted Diagnosis Software Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Medical AI-assisted Diagnosis Software Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Medical AI-assisted Diagnosis Software Market Size by Type (2020-2031)
6.4 North America Medical AI-assisted Diagnosis Software Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Medical AI-assisted Diagnosis Software Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Medical AI-assisted Diagnosis Software Market Size by Type (2020-2031)
7.4 Europe Medical AI-assisted Diagnosis Software Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Medical AI-assisted Diagnosis Software Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Medical AI-assisted Diagnosis Software Market Size by Type (2020-2031)
8.4 Asia-Pacific Medical AI-assisted Diagnosis Software Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Medical AI-assisted Diagnosis Software Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Medical AI-assisted Diagnosis Software Market Size by Type (2020-2031)
9.4 Central and South America Medical AI-assisted Diagnosis Software Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Medical AI-assisted Diagnosis Software Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Medical AI-assisted Diagnosis Software Market Size by Type (2020-2031)
10.4 Middle East and Africa Medical AI-assisted Diagnosis Software Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Medical AI-assisted Diagnosis Software Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Sense Time
11.1.1 Sense Time Corporation Information
11.1.2 Sense Time Business Overview
11.1.3 Sense Time Medical AI-assisted Diagnosis Software Product Features and Attributes
11.1.4 Sense Time Medical AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.1.5 Sense Time Medical AI-assisted Diagnosis Software Revenue by Product in 2024
11.1.6 Sense Time Medical AI-assisted Diagnosis Software Revenue by Application in 2024
11.1.7 Sense Time Medical AI-assisted Diagnosis Software Revenue by Geographic Area in 2024
11.1.8 Sense Time Medical AI-assisted Diagnosis Software SWOT Analysis
11.1.9 Sense Time Recent Developments
11.2 United Imaging
11.2.1 United Imaging Corporation Information
11.2.2 United Imaging Business Overview
11.2.3 United Imaging Medical AI-assisted Diagnosis Software Product Features and Attributes
11.2.4 United Imaging Medical AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.2.5 United Imaging Medical AI-assisted Diagnosis Software Revenue by Product in 2024
11.2.6 United Imaging Medical AI-assisted Diagnosis Software Revenue by Application in 2024
11.2.7 United Imaging Medical AI-assisted Diagnosis Software Revenue by Geographic Area in 2024
11.2.8 United Imaging Medical AI-assisted Diagnosis Software SWOT Analysis
11.2.9 United Imaging Recent Developments
11.3 Huiying Medical
11.3.1 Huiying Medical Corporation Information
11.3.2 Huiying Medical Business Overview
11.3.3 Huiying Medical Medical AI-assisted Diagnosis Software Product Features and Attributes
11.3.4 Huiying Medical Medical AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.3.5 Huiying Medical Medical AI-assisted Diagnosis Software Revenue by Product in 2024
11.3.6 Huiying Medical Medical AI-assisted Diagnosis Software Revenue by Application in 2024
11.3.7 Huiying Medical Medical AI-assisted Diagnosis Software Revenue by Geographic Area in 2024
11.3.8 Huiying Medical Medical AI-assisted Diagnosis Software SWOT Analysis
11.3.9 Huiying Medical Recent Developments
11.4 Yizhun
11.4.1 Yizhun Corporation Information
11.4.2 Yizhun Business Overview
11.4.3 Yizhun Medical AI-assisted Diagnosis Software Product Features and Attributes
11.4.4 Yizhun Medical AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.4.5 Yizhun Medical AI-assisted Diagnosis Software Revenue by Product in 2024
11.4.6 Yizhun Medical AI-assisted Diagnosis Software Revenue by Application in 2024
11.4.7 Yizhun Medical AI-assisted Diagnosis Software Revenue by Geographic Area in 2024
11.4.8 Yizhun Medical AI-assisted Diagnosis Software SWOT Analysis
11.4.9 Yizhun Recent Developments
11.5 BioMind
11.5.1 BioMind Corporation Information
11.5.2 BioMind Business Overview
11.5.3 BioMind Medical AI-assisted Diagnosis Software Product Features and Attributes
11.5.4 BioMind Medical AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.5.5 BioMind Medical AI-assisted Diagnosis Software Revenue by Product in 2024
11.5.6 BioMind Medical AI-assisted Diagnosis Software Revenue by Application in 2024
11.5.7 BioMind Medical AI-assisted Diagnosis Software Revenue by Geographic Area in 2024
11.5.8 BioMind Medical AI-assisted Diagnosis Software SWOT Analysis
11.5.9 BioMind Recent Developments
11.6 Shukun
11.6.1 Shukun Corporation Information
11.6.2 Shukun Business Overview
11.6.3 Shukun Medical AI-assisted Diagnosis Software Product Features and Attributes
11.6.4 Shukun Medical AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.6.5 Shukun Recent Developments
11.7 Lepu Medical
11.7.1 Lepu Medical Corporation Information
11.7.2 Lepu Medical Business Overview
11.7.3 Lepu Medical Medical AI-assisted Diagnosis Software Product Features and Attributes
11.7.4 Lepu Medical Medical AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.7.5 Lepu Medical Recent Developments
11.8 Infervision
11.8.1 Infervision Corporation Information
11.8.2 Infervision Business Overview
11.8.3 Infervision Medical AI-assisted Diagnosis Software Product Features and Attributes
11.8.4 Infervision Medical AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.8.5 Infervision Recent Developments
11.9 NeuMiva
11.9.1 NeuMiva Corporation Information
11.9.2 NeuMiva Business Overview
11.9.3 NeuMiva Medical AI-assisted Diagnosis Software Product Features and Attributes
11.9.4 NeuMiva Medical AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.9.5 NeuMiva Recent Developments
11.10 Baidu Lingyi
11.10.1 Baidu Lingyi Corporation Information
11.10.2 Baidu Lingyi Business Overview
11.10.3 Baidu Lingyi Medical AI-assisted Diagnosis Software Product Features and Attributes
11.10.4 Baidu Lingyi Medical AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Tencent Health
11.11.1 Tencent Health Corporation Information
11.11.2 Tencent Health Business Overview
11.11.3 Tencent Health Medical AI-assisted Diagnosis Software Product Features and Attributes
11.11.4 Tencent Health Medical AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.11.5 Tencent Health Recent Developments
11.12 Deepwise
11.12.1 Deepwise Corporation Information
11.12.2 Deepwise Business Overview
11.12.3 Deepwise Medical AI-assisted Diagnosis Software Product Features and Attributes
11.12.4 Deepwise Medical AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.12.5 Deepwise Recent Developments
11.13 VoxelCloud
11.13.1 VoxelCloud Corporation Information
11.13.2 VoxelCloud Business Overview
11.13.3 VoxelCloud Medical AI-assisted Diagnosis Software Product Features and Attributes
11.13.4 VoxelCloud Medical AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.13.5 VoxelCloud Recent Developments
11.14 Wision
11.14.1 Wision Corporation Information
11.14.2 Wision Business Overview
11.14.3 Wision Medical AI-assisted Diagnosis Software Product Features and Attributes
11.14.4 Wision Medical AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.14.5 Wision Recent Developments
11.15 ZHENHEALTH
11.15.1 ZHENHEALTH Corporation Information
11.15.2 ZHENHEALTH Business Overview
11.15.3 ZHENHEALTH Medical AI-assisted Diagnosis Software Product Features and Attributes
11.15.4 ZHENHEALTH Medical AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.15.5 ZHENHEALTH Recent Developments
11.16 G K Healthcare
11.16.1 G K Healthcare Corporation Information
11.16.2 G K Healthcare Business Overview
11.16.3 G K Healthcare Medical AI-assisted Diagnosis Software Product Features and Attributes
11.16.4 G K Healthcare Medical AI-assisted Diagnosis Software Revenue and Gross Margin (2020-2025)
11.16.5 G K Healthcare Recent Developments
12 Medical AI-assisted Diagnosis SoftwareIndustry Chain Analysis
12.1 Medical AI-assisted Diagnosis Software Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Medical AI-assisted Diagnosis Software Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Medical AI-assisted Diagnosis Software Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Medical AI-assisted Diagnosis Software Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Medical AI-assisted Diagnosis Software Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Medical AI-assisted Diagnosis Software Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Medical AI-assisted Diagnosis Software Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Medical AI-assisted Diagnosis Software Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Medical AI-assisted Diagnosis Software Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Medical AI-assisted Diagnosis Software Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Medical AI-assisted Diagnosis Software by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical AI-assisted Diagnosis Software as of 2024)
 Table 11. Global Medical AI-assisted Diagnosis Software Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Medical AI-assisted Diagnosis Software Companies Headquarters
 Table 13. Global Medical AI-assisted Diagnosis Software Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Medical AI-assisted Diagnosis Software Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Medical AI-assisted Diagnosis Software Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Medical AI-assisted Diagnosis Software Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Medical AI-assisted Diagnosis Software Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Medical AI-assisted Diagnosis Software High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Medical AI-assisted Diagnosis Software Growth Accelerators and Market Barriers
 Table 25. North America Medical AI-assisted Diagnosis Software Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Medical AI-assisted Diagnosis Software Growth Accelerators and Market Barriers
 Table 27. Europe Medical AI-assisted Diagnosis Software Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Medical AI-assisted Diagnosis Software Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Medical AI-assisted Diagnosis Software Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Medical AI-assisted Diagnosis Software Investment Opportunities and Key Challenges
 Table 31. Central and South America Medical AI-assisted Diagnosis Software Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Medical AI-assisted Diagnosis Software Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Medical AI-assisted Diagnosis Software Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Sense Time Corporation Information
 Table 35. Sense Time Description and Major Businesses
 Table 36. Sense Time Product Features and Attributes
 Table 37. Sense Time Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Sense Time Revenue Proportion by Product in 2024
 Table 39. Sense Time Revenue Proportion by Application in 2024
 Table 40. Sense Time Revenue Proportion by Geographic Area in 2024
 Table 41. Sense Time Medical AI-assisted Diagnosis Software SWOT Analysis
 Table 42. Sense Time Recent Developments
 Table 43. United Imaging Corporation Information
 Table 44. United Imaging Description and Major Businesses
 Table 45. United Imaging Product Features and Attributes
 Table 46. United Imaging Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. United Imaging Revenue Proportion by Product in 2024
 Table 48. United Imaging Revenue Proportion by Application in 2024
 Table 49. United Imaging Revenue Proportion by Geographic Area in 2024
 Table 50. United Imaging Medical AI-assisted Diagnosis Software SWOT Analysis
 Table 51. United Imaging Recent Developments
 Table 52. Huiying Medical Corporation Information
 Table 53. Huiying Medical Description and Major Businesses
 Table 54. Huiying Medical Product Features and Attributes
 Table 55. Huiying Medical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Huiying Medical Revenue Proportion by Product in 2024
 Table 57. Huiying Medical Revenue Proportion by Application in 2024
 Table 58. Huiying Medical Revenue Proportion by Geographic Area in 2024
 Table 59. Huiying Medical Medical AI-assisted Diagnosis Software SWOT Analysis
 Table 60. Huiying Medical Recent Developments
 Table 61. Yizhun Corporation Information
 Table 62. Yizhun Description and Major Businesses
 Table 63. Yizhun Product Features and Attributes
 Table 64. Yizhun Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Yizhun Revenue Proportion by Product in 2024
 Table 66. Yizhun Revenue Proportion by Application in 2024
 Table 67. Yizhun Revenue Proportion by Geographic Area in 2024
 Table 68. Yizhun Medical AI-assisted Diagnosis Software SWOT Analysis
 Table 69. Yizhun Recent Developments
 Table 70. BioMind Corporation Information
 Table 71. BioMind Description and Major Businesses
 Table 72. BioMind Product Features and Attributes
 Table 73. BioMind Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. BioMind Revenue Proportion by Product in 2024
 Table 75. BioMind Revenue Proportion by Application in 2024
 Table 76. BioMind Revenue Proportion by Geographic Area in 2024
 Table 77. BioMind Medical AI-assisted Diagnosis Software SWOT Analysis
 Table 78. BioMind Recent Developments
 Table 79. Shukun Corporation Information
 Table 80. Shukun Description and Major Businesses
 Table 81. Shukun Product Features and Attributes
 Table 82. Shukun Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Shukun Recent Developments
 Table 84. Lepu Medical Corporation Information
 Table 85. Lepu Medical Description and Major Businesses
 Table 86. Lepu Medical Product Features and Attributes
 Table 87. Lepu Medical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Lepu Medical Recent Developments
 Table 89. Infervision Corporation Information
 Table 90. Infervision Description and Major Businesses
 Table 91. Infervision Product Features and Attributes
 Table 92. Infervision Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Infervision Recent Developments
 Table 94. NeuMiva Corporation Information
 Table 95. NeuMiva Description and Major Businesses
 Table 96. NeuMiva Product Features and Attributes
 Table 97. NeuMiva Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. NeuMiva Recent Developments
 Table 99. Baidu Lingyi Corporation Information
 Table 100. Baidu Lingyi Description and Major Businesses
 Table 101. Baidu Lingyi Product Features and Attributes
 Table 102. Baidu Lingyi Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Baidu Lingyi Recent Developments
 Table 104. Tencent Health Corporation Information
 Table 105. Tencent Health Description and Major Businesses
 Table 106. Tencent Health Product Features and Attributes
 Table 107. Tencent Health Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Tencent Health Recent Developments
 Table 109. Deepwise Corporation Information
 Table 110. Deepwise Description and Major Businesses
 Table 111. Deepwise Product Features and Attributes
 Table 112. Deepwise Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Deepwise Recent Developments
 Table 114. VoxelCloud Corporation Information
 Table 115. VoxelCloud Description and Major Businesses
 Table 116. VoxelCloud Product Features and Attributes
 Table 117. VoxelCloud Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. VoxelCloud Recent Developments
 Table 119. Wision Corporation Information
 Table 120. Wision Description and Major Businesses
 Table 121. Wision Product Features and Attributes
 Table 122. Wision Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. Wision Recent Developments
 Table 124. ZHENHEALTH Corporation Information
 Table 125. ZHENHEALTH Description and Major Businesses
 Table 126. ZHENHEALTH Product Features and Attributes
 Table 127. ZHENHEALTH Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. ZHENHEALTH Recent Developments
 Table 129. G K Healthcare Corporation Information
 Table 130. G K Healthcare Description and Major Businesses
 Table 131. G K Healthcare Product Features and Attributes
 Table 132. G K Healthcare Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. G K Healthcare Recent Developments
 Table 134. Raw Materials Key Suppliers
 Table 135. Distributors List
 Table 136. Market Trends and Market Evolution
 Table 137. Market Drivers and Opportunities
 Table 138. Market Challenges, Risks, and Restraints
 Table 139. Research Programs/Design for This Report
 Table 140. Key Data Information from Secondary Sources
 Table 141. Key Data Information from Primary Sources


List of Figures
 Figure 1. Medical AI-assisted Diagnosis Software Product Picture
 Figure 2. Global Medical AI-assisted Diagnosis Software Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Lung AI-assisted Diagnosis Software Product Picture
 Figure 4. Bone AI-assisted Diagnosis Software Product Picture
 Figure 5. Cardiovascular and Cerebrovascular AI-assisted Diagnosis Software Product Picture
 Figure 6. Breast AI-assisted Diagnosis Software Product Picture
 Figure 7. Ophthalmic AI-assisted Diagnosis Software Product Picture
 Figure 8. Other AI-assisted Diagnosis Software Product Picture
 Figure 9. Global Medical AI-assisted Diagnosis Software Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 10. Hospital
 Figure 11. Clinic
 Figure 12. Imaging Center
 Figure 13. Medical AI-assisted Diagnosis Software Report Years Considered
 Figure 14. Global Medical AI-assisted Diagnosis Software Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Medical AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 16. Global Medical AI-assisted Diagnosis Software Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 17. Global Medical AI-assisted Diagnosis Software Revenue Market Share by Region (2020-2031)
 Figure 18. Global Medical AI-assisted Diagnosis Software Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Lung AI-assisted Diagnosis Software Revenue Market Share by Player in 2024
 Figure 21. Bone AI-assisted Diagnosis Software Revenue Market Share by Player in 2024
 Figure 22. Cardiovascular and Cerebrovascular AI-assisted Diagnosis Software Revenue Market Share by Player in 2024
 Figure 23. Breast AI-assisted Diagnosis Software Revenue Market Share by Player in 2024
 Figure 24. Ophthalmic AI-assisted Diagnosis Software Revenue Market Share by Player in 2024
 Figure 25. Other AI-assisted Diagnosis Software Revenue Market Share by Player in 2024
 Figure 26. Global Medical AI-assisted Diagnosis Software Revenue Market Share by Type (2020-2031)
 Figure 27. Global Medical AI-assisted Diagnosis Software Revenue Market Share by Application (2020-2031)
 Figure 28. North America Medical AI-assisted Diagnosis Software Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. North America Top 5 Players Medical AI-assisted Diagnosis Software Revenue (US$ Million) in 2024
 Figure 30. North America Medical AI-assisted Diagnosis Software Revenue (US$ Million) by Type (2020 - 2031)
 Figure 31. North America Medical AI-assisted Diagnosis Software Revenue (US$ Million) by Application (2020-2031)
 Figure 32. US Medical AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 33. Canada Medical AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 34. Mexico Medical AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 35. Europe Medical AI-assisted Diagnosis Software Revenue YoY (2020-2031) & (US$ Million)
 Figure 36. Europe Top 5 Players Medical AI-assisted Diagnosis Software Revenue (US$ Million) in 2024
 Figure 37. Europe Medical AI-assisted Diagnosis Software Revenue (US$ Million) by Type (2020-2031)
 Figure 38. Europe Medical AI-assisted Diagnosis Software Revenue (US$ Million) by Application (2020-2031)
 Figure 39. Germany Medical AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 40. France Medical AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 41. U.K. Medical AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 42. Italy Medical AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 43. Russia Medical AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 44. Asia-Pacific Medical AI-assisted Diagnosis Software Revenue YoY (2020-2031) & (US$ Million)
 Figure 45. Asia-Pacific Top 8 Players Medical AI-assisted Diagnosis Software Revenue (US$ Million) in 2024
 Figure 46. Asia-Pacific Medical AI-assisted Diagnosis Software Revenue (US$ Million) by Type (2020-2031)
 Figure 47. Asia-Pacific Medical AI-assisted Diagnosis Software Revenue (US$ Million) by Application (2020-2031)
 Figure 48. Indonesia Medical AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 49. Japan Medical AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 50. South Korea Medical AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 51. Australia Medical AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 52. India Medical AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 53. Indonesia Medical AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 54. Vietnam Medical AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 55. Malaysia Medical AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 56. Philippines Medical AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 57. Singapore Medical AI-assisted Diagnosis Software Revenue (2020-2031) & (US$ Million)
 Figure 58. Central and South America Medical AI-assisted Diagnosis Software Revenue YoY (2020-2031) & (US$ Million)
 Figure 59. Central and South America Top 5 Players Medical AI-assisted Diagnosis Software Revenue (US$ Million) in 2024
 Figure 60. Central and South America Medical AI-assisted Diagnosis Software Revenue (US$ Million) by Type (2020-2031)
 Figure 61. Central and South America Medical AI-assisted Diagnosis Software Revenue (US$ Million) by Application (2020-2031)
 Figure 62. Brazil Medical AI-assisted Diagnosis Software Revenue (2020-2025) & (US$ Million)
 Figure 63. Argentina Medical AI-assisted Diagnosis Software Revenue (2020-2025) & (US$ Million)
 Figure 64. Middle East and Africa Medical AI-assisted Diagnosis Software Revenue YoY (2020-2031) & (US$ Million)
 Figure 65. Middle East and Africa Top 5 Players Medical AI-assisted Diagnosis Software Revenue (US$ Million) in 2024
 Figure 66. South America Medical AI-assisted Diagnosis Software Revenue (US$ Million) by Type (2020-2031)
 Figure 67. Middle East and Africa Medical AI-assisted Diagnosis Software Revenue (US$ Million) by Application (2020-2031)
 Figure 68. GCC Countries Medical AI-assisted Diagnosis Software Revenue (2020-2025) & (US$ Million)
 Figure 69. Israel Medical AI-assisted Diagnosis Software Revenue (2020-2025) & (US$ Million)
 Figure 70. Egypt Medical AI-assisted Diagnosis Software Revenue (2020-2025) & (US$ Million)
 Figure 71. South Africa Medical AI-assisted Diagnosis Software Revenue (2020-2025) & (US$ Million)
 Figure 72. Medical AI-assisted Diagnosis Software Industry Chain Mapping
 Figure 73. Channels of Distribution (Direct Vs Distribution)
 Figure 74. Bottom-up and Top-down Approaches for This Report
 Figure 75. Data Triangulation
 Figure 76. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

RELATED REPORTS

Global Isopropyl Alcohol Antiseptic Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37F12574
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15J20209
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Total Foot System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8O12834
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32P14840
Wed Dec 03 00:00:00 UTC 2025

Add to Cart